Purpose of the study
To demonstrate anti-HIV activity in DLE and show DLE modulation on cellular factors involved in HIV replication.
Methods
Using an in vitro infection model on MT4 cell line we study the effect of DLE on HIV replication. We study the effect of DLE on important cellular factors like NFkB, Sp1 and TNF in MT4 cells or peripheral blood mononuclear cells.
Summary of results
DLE shows a significant inhibitory effect on HIV replication ranged from 80-90% according to the viral chal-
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lenge (figure 1). In addition, others results shown DLE modulation of important endogenous factors involved in
HIV immunopathogenesis like TNFa (figure 2) and transcription factors NFB and Sp1.
Conclusions
DLE effect on cellular factors involved in HIV replication correlates with DLE inhibitory effect on HIV in vitro replication. The inhibition of HIV replication observed with DLE treatment could be mediated by inhibition of transcription factors that may promote replication of HIV. Also, it could be mediated or potentiated by modulation TNF and others endogenous factors involved in HIV replication. These finding could support the use of DLE on HIV patients. 
